retatrutide triple agonist obesity trial 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Lilly's triple agonist, retatrutide, delivered

Conclusion PROM developers consider it feasible to involve children younger than 8-years-old in the qualitative development of PROMs in QoL research

As use of GLP-1 receptor agonists continues to expand, the integration of conventional clinical evidence with large-scale observational data may offer a more complete picture of how these therapies affect patients in routine practice

Matthew R Hayes, Heath D Schmidt, GLP-1 influences food and drug reward, Current Opinion in Behavioral Sciences, Volume 9, 2016, Pages 66-70, ISSN 2352-1546 Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J

Despite the claims, Abbott and Mead Johnson deny the allegations, arguing that their products are thoroughly researched and dismissing the scientific evidence linking their formulas to NEC, while the FDA issued a warning to Abbott regarding safety concerns of a formula product

Human growth hormone is a controlled substance in Canada, available legally only with a valid prescription for approved medical indications such as adult growth hormone deficiency

It does not cause gastrointestinal symptoms